Ignite Creation Date:
2024-05-05 @ 6:45 PM
Last Modification Date:
2024-10-26 @ 9:37 AM
Study NCT ID:
NCT00544024
Status:
COMPLETED
Last Update Posted:
2007-10-16
First Post:
2007-10-12
Brief Title:
Mefloquine Bioequivalence Among 3 Commercially Available Tablets
Sponsor:
Organization:
Centers for Disease Control and Prevention
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
NONE_RETAINED
Bio Spec Description:
Whole blood was obtained for analysis but has been subsequently disposed after completion of drug analysis
Enrollment Count:
39
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 3951 |
Who Masked List: